Cliff Asness's NVAX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 902,650 shares of Novavax, Inc. (NVAX) worth $8.5 M, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 790,593 shares. Largest reduction occurred in Q1 2026, reducing 34,676 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +790,593 | Add 705.53% | 902,650 | $9.42 |
| Q1 2026 | -34,676 | Reduce 23.63% | 112,057 | $8.14 |
| Q4 2025 | -32,977 | Reduce 18.35% | 146,733 | $6.72 |
| Q3 2025 | +162,111 | Add 921.14% | 179,710 | $8.67 |
| Q2 2025 | -26,828 | Reduce 60.39% | 17,599 | $6.30 |
| Q1 2025 | +21,663 | Add 95.16% | 44,427 | $6.41 |
| Q4 2024 | +4,007 | Add 21.36% | 22,764 | $8.04 |
| Q3 2024 | +18,757 | New Buy | 18,757 | $12.63 |
| Q1 2022 | -1,573 | Sold Out | 0 | $0.00 |
| Q4 2021 | +1,573 | New Buy | 1,573 | $143.04 |
| Q3 2021 | -28,679 | Sold Out | 0 | $0.00 |
| Q2 2021 | -13,101 | Reduce 31.36% | 28,679 | $212.32 |
| Q1 2021 | +854 | Add 2.09% | 41,780 | $181.31 |
| Q4 2020 | -6,598 | Reduce 13.88% | 40,926 | $111.52 |
| Q3 2020 | +25,039 | Add 111.36% | 47,524 | $108.35 |
| Q2 2020 | +22,485 | New Buy | 22,485 | $83.34 |
Cliff Asness's Novavax Investment FAQs
Cliff Asness first purchased Novavax, Inc. (NVAX) in Q2 2020, acquiring 22,485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Novavax, Inc. (NVAX) for 16 quarters since Q2 2020.
Cliff Asness's largest addition to Novavax, Inc. (NVAX) was in Q2 2026, adding 902,650 shares worth $8.5 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 902,650 shares of Novavax, Inc. (NVAX), valued at approximately $8.5 M.
As of the Q2 2026 filing, Novavax, Inc. (NVAX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Novavax, Inc. (NVAX) was 902,650 shares, as reported at the end of Q2 2026.